Visible Particulate Inspection
What a definition is not
A definition is SPEQ’s plain-language decode of how a term is used in practice, cited to the documents that define it. It is a practitioner reference, not legal or regulatory advice, it does not replace the definition in the source, and where a regulator’s wording differs the regulator’s wording governs.
A 100% manual or automated inspection of every unit of a parenteral or other injectable product, against a defined light-and-dark background under specified illumination, to detect and reject units containing visible particulate matter, extraneous material, or container/closure defects such as cracks or missing components, performed before batch release.
Because it is impractical to remove all particulate risk through process control alone, 100% visible inspection is the final control point catching defects introduced anywhere upstream — from glass delamination to fibre shedding to a stopper fragment — that would otherwise reach the patient.
Human visual inspection is qualified per inspector using a defective-unit reference set with a target detection probability, and inspectors are periodically requalified, since detection performance degrades with fatigue and varies between individuals.
Automated inspection systems, increasingly used for high-volume lines, must themselves be qualified to demonstrate equal or superior detection performance to a qualified human inspector before replacing or supplementing manual inspection.
- —100% inspection of every unit, not a sample — the final defect-detection control before release.
- —Human inspectors are qualified against a defective-unit reference set and periodically requalified.
- —Automated inspection systems require their own qualification against human-inspection performance.
- —Detects container/closure defects as well as particulate matter.
USP <790>; USP <1790>; EU GMP Annex 1 (2022)
Frequently asked questions
What is Visible Particulate Inspection?
A 100% manual or automated inspection of every unit of a parenteral or other injectable product, against a defined light-and-dark background under specified illumination, to detect and reject units containing visible particulate matter, extraneous material, or container/closure defects such as cracks or missing components, performed before batch release.
Which regulations cover Visible Particulate Inspection?
USP <790>; USP <1790>; EU GMP Annex 1 (2022)